Expression of the transcription factor PITX2 in ameloblastic carcinoma
Alejandro García-Muñoz(Universidad Juárez del Estado de Durango), Ronell Bologna‐Molina(Universidad de la República de Uruguay), Carlos Licéaga‐Escalera(Hospital Juárez de México), Ramón Gil Carreón-Burciaga(Universidad de la República de Uruguay), Mario A. Rodríguez(Cordoba University), Rodrigo Liceága-Reyes(Hospital Juárez de México), Rogelio González‐González(Universidad de la República de Uruguay)
Cited by 15
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58